Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Mir

Showing results (21-30 of 506) with videos related to

Pageof 51
Sort By:
Biochemical and Biophysical Research Communications|December 10, 1990
Stable [57Co]-bleomycin complex with a very high specific radioactivity for use at very low concentrationsB Poddevin, J Belehradek, L M Mir
General Pharmacology|July 1, 1996
Bleomycin: revival of an old drugL M Mir, O Tounekti, S Orlowski
Biochemical and Biophysical Research Communications|July 15, 1993
Identification of a plasma membrane protein that specifically binds bleomycinG Pron, J Belehradek, L M Mir
Biochemical and Biophysical Research Communications|March 15, 1989
Voltage-dependent introduction of a d[alpha]octothymidylate into electropermeabilized cellsD Bazile, L M Mir, C Paoletti
Experimental Cell Research|April 1, 1995
Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosisO Tounekti, J Belehradek, L M Mir
European Journal of Biochemistry|March 1, 1997
Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite modelM Garrigos, L M Mir, S Orlowski
Cancer Research|November 15, 1993
Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalizedO Tounekti, G Pron, J Belehradek, et al.
Biochemical Pharmacology|July 19, 1994
Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicityG Pron, J Belehradek, S Orlowski, et al.
The Biochemical Journal|July 15, 1996
Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulatorsS Orlowski, L M Mir, J Belehradek, et al.
Annals of Biomedical Engineering|March 18, 2005
Tissue ablation with irreversible electroporationR V Davalos, I L M Mir, B Rubinsky
Pageof 51

Showing results (21-30 of 506) with videos related to

Sort By:
Pageof 51
Biochemical and Biophysical Research Communications|December 10, 1990
Stable [57Co]-bleomycin complex with a very high specific radioactivity for use at very low concentrationsB Poddevin, J Belehradek, L M Mir
General Pharmacology|July 1, 1996
Bleomycin: revival of an old drugL M Mir, O Tounekti, S Orlowski
Biochemical and Biophysical Research Communications|July 15, 1993
Identification of a plasma membrane protein that specifically binds bleomycinG Pron, J Belehradek, L M Mir
Biochemical and Biophysical Research Communications|March 15, 1989
Voltage-dependent introduction of a d[alpha]octothymidylate into electropermeabilized cellsD Bazile, L M Mir, C Paoletti
Experimental Cell Research|April 1, 1995
Relationships between DNA fragmentation, chromatin condensation, and changes in flow cytometry profiles detected during apoptosisO Tounekti, J Belehradek, L M Mir
European Journal of Biochemistry|March 1, 1997
Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite modelM Garrigos, L M Mir, S Orlowski
Cancer Research|November 15, 1993
Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalizedO Tounekti, G Pron, J Belehradek, et al.
Biochemical Pharmacology|July 19, 1994
Involvement of membrane bleomycin-binding sites in bleomycin cytotoxicityG Pron, J Belehradek, S Orlowski, et al.
The Biochemical Journal|July 15, 1996
Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulatorsS Orlowski, L M Mir, J Belehradek, et al.
Annals of Biomedical Engineering|March 18, 2005
Tissue ablation with irreversible electroporationR V Davalos, I L M Mir, B Rubinsky
Pageof 51